National Medical Care Company (TADAWUL:4005)
Saudi Arabia
· Delayed Price · Currency is SAR 118.10
-0.90 (-0.76%)
Apr 29, 2026, 3:17 PM AST
TADAWUL:4005 Ratios and Metrics
Market cap in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 5,318 | 6,377 | 7,463 | 7,822 | 3,314 | 2,808 | Upgrade
|
| Market Cap Growth | -20.56% | -14.55% | -4.58% | 136.00% | 18.05% | 17.23% | Upgrade
|
| Enterprise Value | 5,304 | 6,429 | 7,514 | 7,213 | 3,266 | 2,550 | Upgrade
|
| Last Close Price | 119.00 | 142.70 | 164.97 | 170.30 | 71.58 | 59.79 | Upgrade
|
| PE Ratio | 16.70 | 20.02 | 25.33 | 32.47 | 19.49 | 20.59 | Upgrade
|
| Forward PE | 16.43 | 17.86 | 23.45 | 29.16 | 20.89 | 19.68 | Upgrade
|
| PS Ratio | 3.32 | 3.99 | 5.77 | 7.23 | 3.61 | 3.32 | Upgrade
|
| PB Ratio | 2.88 | 3.45 | 4.59 | 5.38 | 2.62 | 2.50 | Upgrade
|
| P/TBV Ratio | 3.12 | 3.75 | 5.05 | 5.84 | 2.63 | 2.51 | Upgrade
|
| P/FCF Ratio | 198.44 | 237.96 | 54.62 | 18.95 | 17.84 | 45.57 | Upgrade
|
| P/OCF Ratio | 34.54 | 41.42 | 30.51 | 16.76 | 15.28 | 29.93 | Upgrade
|
| PEG Ratio | - | 1.26 | 1.51 | 1.48 | 2.04 | 2.04 | Upgrade
|
| EV/Sales Ratio | 3.31 | 4.02 | 5.81 | 6.67 | 3.56 | 3.02 | Upgrade
|
| EV/EBITDA Ratio | 11.44 | 14.69 | 23.85 | 24.79 | 13.66 | 11.88 | Upgrade
|
| EV/EBIT Ratio | 14.96 | 18.13 | 29.93 | 29.24 | 16.56 | 15.51 | Upgrade
|
| EV/FCF Ratio | 197.89 | 239.90 | 55.00 | 17.48 | 17.58 | 41.38 | Upgrade
|
| Debt / Equity Ratio | 0.28 | 0.28 | 0.30 | 0.23 | 0.07 | 0.08 | Upgrade
|
| Debt / EBITDA Ratio | 1.11 | 1.11 | 1.46 | 1.11 | 0.35 | 0.42 | Upgrade
|
| Debt / FCF Ratio | 19.26 | 19.26 | 3.57 | 0.80 | 0.45 | 1.45 | Upgrade
|
| Net Debt / Equity Ratio | -0.01 | -0.01 | -0.05 | -0.25 | -0.19 | -0.25 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.03 | -0.03 | -0.25 | -1.25 | -1.03 | -1.33 | Upgrade
|
| Net Debt / FCF Ratio | -0.54 | -0.54 | -0.58 | -0.88 | -1.32 | -4.64 | Upgrade
|
| Asset Turnover | 0.61 | 0.61 | 0.55 | 0.55 | 0.56 | 0.56 | Upgrade
|
| Inventory Turnover | 16.71 | 16.71 | 15.34 | 14.95 | 14.26 | 13.11 | Upgrade
|
| Quick Ratio | 3.93 | 3.93 | 3.29 | 3.45 | 3.47 | 3.88 | Upgrade
|
| Current Ratio | 4.30 | 4.30 | 3.53 | 3.68 | 3.69 | 4.20 | Upgrade
|
| Return on Equity (ROE) | 18.33% | 18.33% | 19.14% | 17.73% | 14.24% | 12.62% | Upgrade
|
| Return on Assets (ROA) | 8.41% | 8.41% | 6.66% | 7.85% | 7.54% | 6.87% | Upgrade
|
| Return on Invested Capital (ROIC) | 17.75% | 19.28% | 19.04% | 21.32% | 18.21% | 17.07% | Upgrade
|
| Return on Capital Employed (ROCE) | 14.60% | 14.60% | 11.70% | 13.20% | 13.80% | 12.60% | Upgrade
|
| Earnings Yield | 5.99% | 4.99% | 3.95% | 3.08% | 5.13% | 4.86% | Upgrade
|
| FCF Yield | 0.50% | 0.42% | 1.83% | 5.28% | 5.61% | 2.20% | Upgrade
|
| Dividend Yield | 2.52% | 2.10% | 1.21% | 1.17% | 1.40% | 1.67% | Upgrade
|
| Payout Ratio | 28.07% | 28.07% | 30.44% | 18.62% | 26.37% | 32.89% | Upgrade
|
| Buyback Yield / Dilution | 0.17% | 0.17% | 0.18% | - | - | - | Upgrade
|
| Total Shareholder Return | 2.74% | 2.27% | 1.40% | 1.17% | 1.40% | 1.67% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.